Sanaby Health Acquisition I priced its IPO of 15 million units at $10 each. Units list on the Nasdaq and begin trading today under SANBU. Each consists of one share of Class A common stock and a redeemable warrant, with each whole warrant exercisable to purchase one share at $11.50. After the securities begin separate trading, shares and warrants are expected to list under SANB and SANBW.
The offering is expected to close Oct. 19.
Sanaby Health intends to identify opportunities in the healthcare industry, with a focus on digital health, life science tools and services, and innovative therapeutics.
Cohen & Company Capital Markets is advising the company.
BTIG is sole book-runner for the offering. I-Bankers Securities, Inc. is co-manager. The underwriters have an option to purchase up to an additional 2.25 million units to cover over-allotments, if any. Read more.
